Michael Wood
Pediatric Endocrinology · Ypsilanti, MINPI 1801866363
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $48,118 of the $58,969 with a category attached, or 81.6%. 36 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 48.9% of the total. 2025 is the largest year on record at $46,510, more than ten times the $1,007 reported in 2019. Among pediatric endocrinology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 246 payments — averaging $239.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$29K
- AstraZeneca$18K
- Lilly USA, LLC$5K
- Mannkind Corporation$3K
- Novo Nordisk$623
- Ascensia Diabetes Care US Inc.$491
- plus $3K from 30 others
Across 169 payments — averaging $818.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$89K
- Mannkind Corporation$49K
What the payments were for
- Consulting fees$2,4254%
- Speaking & faculty fees$48,11882%
- Travel & lodging$4,0937%
- Food & beverage$4,1487%
- Education$1860%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 19 | $28,826 |
| AstraZeneca | 28 | $18,444 |
| Lilly USA, LLC | 5 | $5,239 |
| Mannkind Corporation | 37 | $2,685 |
| Novo Nordisk | 29 | $623 |
| Ascensia Diabetes Care US Inc. | 3 | $491 |
| Tandem Diabetes Care, Inc. | 5 | $455 |
| Pfizer | 13 | $257 |
| Tolmar, Inc. | 7 | $225 |
| Medtronic | 6 | $208 |
| BETA Bionics, Inc. | 1 | $197 |
| Inari Medical, Inc. | 1 | $168 |
| Amarin Pharma, Inc. | 2 | $136 |
| Tolmar Pharmaceuticals, Inc. | 44 | $118 |
| Insulet Corporation | 5 | $93 |
| Ascendis Pharma Endocrinology Inc | 6 | $90 |
| Amphastar Pharmaceuticals, Inc. | 3 | $61 |
| Eton Pharmaceuticals, Inc. | 2 | $61 |
| Sequel Med Tech, LLC | 3 | $59 |
| Azurity Pharmaceuticals, Inc. | 3 | $58 |
| Covidien LP | 1 | $55 |
| Amneal Pharmaceuticals LLC | 3 | $44 |
| Rhythm Pharmaceuticals, Inc. | 2 | $42 |
| Abbott | 2 | $40 |
| Dexcom, Inc. | 2 | $39 |
| Embecta Corp. | 2 | $34 |
| AbbVie | 2 | $33 |
| Zealand Pharma US, Inc. | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 1 | $26 |
| Endo Pharmaceuticals Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Lifescan, Inc. | 1 | $21 |
| Biomarin Pharmaceutical Inc. | 1 | $18 |
| Amgen | 1 | $16 |
| Amryt Pharma Holdings Ltd | 1 | $16 |
| IBSA Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$28,549
- Strensiq$5,470
- LYUMJEV$5,225
- AFREZZA$2,125
- iLet Bionic Pancreas$590
- EVERSENSE E3 SENSOR KIT - RETAIL$450
- t-slim insulin pump$365
- FLOWTRIEVER CATHETER, S$168
- CT THROMBECTOMY SYSTEM KIT$168
- Vascepa$123
- Norditropin$122
- FENSOLVI$114
How this compares
$58,969 in reported general payments places this provider in the 95th percentile of 27 pediatric endocrinology providers in Michigan.
Other pediatric endocrinology in Ypsilanti
- Joyce LeeAnn Arbor$9K
- Jacalyn BishopNovi$9K
- Daniel ShumerAnn Arbor$8K
- Julie SurhighRoyal Oak$5K
- Kathleen MoltzDetroit$4K
- Daniel ElsholzSaginaw$3K
- Ayman AkkadDearborn$2K
- Kanakadurga SingerAnn Arbor$2K
- Colleen Buggs-SaxtonDetroit$2K
- Christel KeefeGrand Rapids$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.